Bruker Responds to District Court’s Ruling on GeoMx Products
BILLERICA, Mass. – Bruker Corporation (NASDAQ: BRKR) recently issued its comments following the ruling by the U.S. District Court for the District of Delaware regarding the GeoMx Digital Spatial Profiler products. This ruling is linked to a patent infringement case that involved its NanoString business, specifically tied to the recent jury verdict against them.
Understanding the Court's Ruling
The District Court upheld a jury’s damages award totaling approximately $31.6 million, plus interest and adjustments related to GeoMx sales post-verdict. Although the court declined the request from the opposing party for heightened damages and legal fees, it did indicate that an injunction against new sales of GeoMx products in the U.S. would be granted. Importantly, the proposed injunction will allow existing customers of GeoMx to purchase consumables needed to complete their ongoing research initiatives.
Key Details Surrounding the Injunction
The precise terms of the injunction, including any allowances for existing customers, are anticipated to be detailed in the following weeks. The ruling itself is not expected to impact other Bruker product lines such as CosMx® or nCounter®, both of which were acquired in a previous asset purchase transaction.
Bruker’s Position on the Ruling
Bruker, represented by Todd Garland, President of the Spatial Biology division, expressed disagreement with the ruling. He stated that the company plans to seek a stay of the injunction while emphasizing their assertion that the patents held by the opposing party are invalid. Bruker is eager to have their case reviewed by the U.S. Court of Appeals for the Federal Circuit, which specializes in patent issues. They advocate for the scientific community's right to choose their tools for spatial biology research.
Bruker’s Commitment to Innovation in Science
As a leader in the post-genomic era, Bruker is dedicated to enabling scientific advancements and discoveries through their high-performance instruments. These tools play a critical role in various research fields, ranging from life sciences to diagnostics. The company prides itself on working closely with customers to drive innovation and productivity in molecular and cellular research.
Bruker's Product Lines and Research Focus
Bruker’s portfolio encompasses a wide range of products that aid in preclinical imaging, proteomics, and spatial biology. As they navigate through the current legal landscape, Bruker remains focused on maintaining the integrity of their offerings in areas crucial for advancements in health and technology, such as analytical solutions and next-gen semiconductor metrology.
Frequently Asked Questions
What was the main outcome of the court ruling?
The court upheld a jury’s damages award of about $31.6 million and indicated plans for an injunction against new sales of GeoMx products in the U.S.
How does the ruling affect Bruker’s product lines?
The ruling impacts GeoMx products but does not affect the CosMx or nCounter product lines.
What is Bruker's stance on the patent infringement issue?
Bruker disagrees with the ruling and plans to seek a stay of the injunction, asserting that the patents involved are invalid.
What is Bruker's role in the scientific community?
Bruker enables scientists and engineers to make significant discoveries and enhance human quality of life through innovative scientific instruments.
How can I find more information about Bruker Corporation?
For more information, you can visit Bruker’s official website at www.bruker.com.
